) 17.28 Profit (Loss) before tax (13.59) 18.35 3.60 41.69 Net Profit (Loss) (14.61) 15.09 0.32 34.65 Total Revenues: EASON recorded a 2% growth in revenues for the second quarter of 2019, however; 6 months
goods and rendering of services in Q2/2018 was recorded at Baht 684 million, higher 19% Y-O-Y, which can be presented by sales channels as follows: - Project up 23% Y-O-Y driven by the continued growth in
”), the subsidiary, has indicated the growth by 12.35%. Costs and Expenses The Company reported the consolidated costs and expenses for Q3/2019 of Baht 365.61 million representing a slightly increase by
million, a 9 .74% or Baht 37.72 million growing up from the same period of previous year. The hospital revenues grew by 10.04% mainly due to the increase in medical service income from Social Security
SMEs for funding in order to develop their potential and increase their ability to compete both domestically and internationally which is SEC's mission under the master plan of the 20-Year National
the contribution of TST Tower of THB 6mn and the increase in rental income of Gracechurch Street office building. Other income grew 16.8% YoY or THB 21mn. The growth in other income was primarily from
should continue to be accommodative so that the economic growth could continue and translate into the strengthening of domestic demand. Notwithstanding this, there are pockets of risks, such as debt
branded sales continued to grow remarkably by c.60%, while domestic CMG are back on track for growth from recovered sales plus good feedback of the new product. Q3/2017 sales grew 9% QoQ due to recovery
% year-on-year. Such growth was driven by บริษัท อินเตอร์ ฟาร์มา จาํกัด เลขที่ 140/9 อาคารไอทเีอฟ ชัน้ 9 ถนนสีลม แขวงสุริวงศ์ เขตบางรัก กรุงเทพมหานคร 10500 โทรศัพท์ 02-634-0225 แฟ็กซ์ 02-634-0135